Endowment Gift Establishes Haworth Family Pediatric Oncology Innovative Therapeutics Clinic at Helen Devos Children’s Hospital
Children fighting cancer have new hope thanks to an endowment gift from Dick and Ethie Haworth to the Helen DeVos Children’s Hospital Foundation. Their major gift establishes the Haworth Family[...]
Research: Beat Childhood Cancer
The Beat Childhood Cancer Research Consortium is a group of 54+ universities and children's hospitals
On Friday was Penn State College of Medicine Pediatric Research Day, where our lab team and interns from this summer presented their work over the course of the past year.
One of our intern's, Madison Rozwat, and our BCC Assistant Professor, Jeremy Hengst, were also asked to give oral presentations on this research.
We are very proud of our Lab team as they help utilize the samples and resources from our clinical trials to move research forward into even more future clinical trials!
Beat Childhood Cancer Research Consortium welcomes The Pediatric Cancer Center Barcelona (PCCB) at Hospital Sant Joan de Déu as the first center outside North America to join the Consortium.
This is a major milestone in our mission to accelerate access to life-saving therapies for children worldwide.
The first study the site will open is our BCC018 trial using naxitamab as a first-line treatment in newly diagnosed patients with high-risk neuroblastoma.
Find Penn State's full press release here: pennstatehealthnews.org/2025/11/penn-states-beat-childhood-cancer-research-consortium-welcomes-sj...
We had the honor and the privilege to visit the Sant Joan de Déu (SJD) Children’s Hospital in Barcelona Spain led by Dr. Jaume Mora. Dr Mora is the scientific director of Oncology and Hematology at the SJD Pediatric Cancer Center and director of the developmental tumours laboratory.
The hospital and teams we met were amazing! The facility brings together the healthcare services aimed at patients with cancer in one single place, as well as spaces dedicated to research. The aim is to treat a large volume of patients more effectively, efficiently and adequately, > 400 new patients per year, with a highly specialised team.
We also got to watch the “step up” protocol of the naxitamab infusion, studied by Dr. Mora and his team, that titrates the dose and uses a different premedication regimen that is much better tolerated by the patient. We saw this difference in side effects first hand and are eager to advocate to our sites to move to this approach for a better patient experience.
We are excited for Dr. Mora and his team to be our first BCC site outside of North America! 🌎🇪🇸🔬
That is a wrap on our time at the Society of International Pediatric Oncology Conference! Thanks for everyone that stopped by our booth and connected with us throughout the meeting. The scientific program was very strong and we were honored to participate again this year! #pennstateuniversity #siop2025 #pediatriconcology #research
The International Society of Paediatric Oncology (SIOP) 2025 Conference will take place in Amsterdam, Netherlands, from October 20 to 23. This conference will feature cutting-edge science and networking opportunities in pediatric oncology on a global level.
We will be at Booth #01 and are looking forward to connecting. Please stop by if you will be in attendance!
In a rapidly evolving landscape of pediatric oncology, precision medicine is redefining how we understand, diagnose, and treat childhood cancers. This expert panel that we hosted at the Advancing Precision Medicine Conference brought together leaders in genomics, bioinformatics, proteomics, immunotherapy and clinical practice to spotlight innovations in precision medicine that are personalizing care for our young patients. The panel explored how to bridge the translational divide between research and real world clinical application. We must foster this interdisciplinary collaboration to accelerate progress. #advancingprecisionmedicine #education #innovation #implementation #PersonalizedCancerCare #pediatriccancer